Stem Cell Clinic

Adult Stem Cell Therapy – regenocyte.com

By adminApril 28, 2019Adult Stem Cells

For more than 40 years, adult stem cells have been used to treat cancer patients. Recent advancements in adult stem cell therapy have been astounding. Cells from an ill patient are being used as part of the treatment. There is no possibility of the body rejecting the new tissue formed, making stem cell treatment safe and effective in achieving positive medical outcomes. It is important to note that adult stem cell therapy is not controversial because it involves the use of a patients own tissues and NOT derived from embryos.

Clinical results from cardiac, pulmonary, neurological, and vascular procedures have shown that the adult stem cell procedures are as safe as traditional procedures and are complimentary to current medical practice.

Visit our Facebook Page and read more about our real life patients and how adult stem cell therapy has changed their lives.

Adult stem cells are extracted from the patients bone marrow and fat (adipose). At Intercellular Sciences, the naturally occurring stem cells in the blood are cultivated into millions of Regenocyte Adult Stem Cells. The Regenocyte Stem Cells are produced in our international treatment center and are administered into the area of need for the patient. Once injected, they stimulate tissue re-growth and greater blood flow to the affected areas. The goal of the treatment is to replace damaged cells and to promote the growth of new blood vessels and tissues in order to help the target organ function at a greater capacity. There is no risk of rejection since the Adult Stem Cells received are directly from the patient. Regenocyte Adult Stem Cell Therapy is safe, highly effective and presents minimal risk.

Stem Cell Treatment: Cardiac

Stem Cell Treatment: Pulmonary

Stem Cell Treatment: Vascular

Stem Cell Treatment: Neurologic

If you think that adult stem cell therapy treatment may be out of reach for your health issues, it is not. Treatment is available today. Regenocyte Adult Stem Cell Therapy results have exceeded expectations. For more information on Intercellular Sciences treatments, results, and updates on advances in adult stem cell therapy, please register for our newsletter today.

To find out more today, click here or call us at (866) 216-5710

Read this article:
Adult Stem Cell Therapy - regenocyte.com

Summary: What is an Adult Stem Cell? | Stem Cells Portal …

By adminApril 28, 2019Adult Stem Cells

Adult stem cells can proliferate without differentiating for a long period (a characteristic referred to as long-term self-renewal), and they can give rise to mature cell types that have characteristic shapes and specialized functions.

Some adult stem cells have the capability to differentiate into tissues other than the ones from which they originated; this is referred to as plasticity.

Adult stem cells are rare. Often they are difficult to identify and their origins are not known. Current methods for characterizing adult stem cells are dependent on determining cell surface markers and observations about their differentiation patterns in test tubes and culture dishes.

To date, published scientific literature indicates that adult stem cells have been derived from brain, bone marrow, peripheral blood, dental pulp, spinal cord, blood vessels, skeletal muscle, epithelia of the skin and digestive system, cornea, retina, liver, and pancreas; thus, adult stem cells have been found in tissues that develop from all three embryonic germ layers.

Hematopoietic stem cells from bone marrow are the most studied and used for clinical applications in restoring various blood and immune components to the bone marrow via transplantation. There are at least two other populations of adult stem cells that have been identified from bone marrow and blood.

Several populations of adult stem cells have been identified in the brain, particularly the hippocampus. Their function is unknown. Proliferation and differentiation of brain stem cells are influenced by various growth factors.

There are now several reports of adult stem cells in other tissues (muscle, blood, and fat) that demonstrate plasticity. Very few published research reports on plasticity of adult stem cells have, however, included clonality studies. That is, there is limited evidence that a single adult stem cell or genetically identical line of adult stem cells demonstrates plasticity.

Rarely have experiments that claim plasticity demonstrated that the adult stem cells have generated mature, fully functional cells or that the cells have restored lost function in vivo.

What are the sources of adult stem cells in the body? Are they "leftover" embryonic stem cells, or do they arise in some other way? And if the latter is truewhich seems to be the caseexactly how do adult stem cells arise, and why do they remain in an undifferentiated state, when all the cells around them have differentiated?

Is it possible to manipulate adult stem cells to increase their ability to proliferate in vitro, so that adult stem cells can be used as a sufficient source of tissue for transplants?

How many kinds of adult stem cells exist, and in which tissues do they exist? Evidence is accumulating that, although they occur in small numbers, adult stem cells are present in many differentiated tissues.

What is the best evidence that adult stem cells show plasticity and generate cell types of other tissues?

Is it possible to manipulate adult stem cells to increase their ability to proliferate in vitro so that adult stem cells can be used as a sufficient source of tissue for transplants?

Is there a universal stem cell? An emerging concept is that, in adult mammals, there may be a population of "universal" stem cells. Although largely theoretical, the concept has some experimental basis. A candidate, universal adult stem cell may be one that circulates in the blood stream, can escape from the blood, and populate various adult tissues. In more than one experimental system, researchers have noted that dividing cells in adult tissues often appear near a blood vessel, such as candidate stem cells in the hippocampus, a region of the brain [75].

Do adult stem cells exhibit plasticity as a normal event in vivo? If so, is this true of all adult stem cells? What are the signals that regulate the proliferation and differentiation of stem cells that demonstrate plasticity?

Excerpt from:
Summary: What is an Adult Stem Cell? | Stem Cells Portal ...

Stem Cell Treatment for Ataxia – Stem Cell Treatment Now

By adminApril 27, 2019Stem Cell Treatment

How does ataxia affect the patient? The disease is characterized by progressively disabling clinical manifestations. Patients show symptoms of gait instability or dysarthria and may begin to fall without warning. Gradually they present progressive limitations in their activities, lose the ability to walk, become bedridden and fully dependent. Other clinical manifestations include astasia, impaired fine motor skillsand intention tremor (cerebellar tremor). The cerebellar syndrome is often associated with other neurological signs such as pyramidal or extrapyramidal signs, ophthalmoplegia, and cognitive impairment.

How to diagnose ataxia? Most people dont know what ataxia is and may overlook the early symptoms. Anyone with progressive gait disorder or imbalance should be evaluated by a neurologist. MRI is recommended in all cases. If a treatable cause is not discovered, a gene test should be done. In about 60 percent of the cases, the gene test will determine the type of ataxia.

What is the efficacy of conventionaltreatments? Until now, conventional treatments are generally used to alleviate the symptoms, not the disease itself. The movement disorders can be managed using pharmacological, physical and occupational therapies to minimize the damage and to promote the mobility as long as possible but overall current treatment remains retardant.

What are the difference between autosomal dominant and autosomal recessive ataxias? Autosomal dominant and autosomal recessive ataxias are hereditary ataxias, and spinocerebellar ataxia (SCA) and Friedreich's ataxia (FRDA) are the most common forms of hereditary ataxia. Autosomal dominant genes express themselves when present. Autosomal recessive genes will only express themselves when in the homozygous state -- i.e., both genes in the gene pair are the recessive gene form. Thus, recessive genes can be "carried" by those whose phenotype does not exhibit the gene characteristic, while dominant genes cannot be "carried". Therefore, generally autosomal dominant ataxias are easier to express andat a higher morbiditythan autosomal recessive ataxias.

What is the role of Purkinje cells, where can we find those cells ? Purkinjecellsare a type of neuron found in the cerebellar cortex, at the base of the brain.They are among the largest neurons and are responsible for most of the electrochemical signaling in the cerebellum. ThePurkinjecellsand the cerebellum are essential to the body's motor function. Disorders involving thePurkinjecellsusually negatively affect the patient's movements.

View post:
Stem Cell Treatment for Ataxia - Stem Cell Treatment Now

Stem Cell Therapy | Lighthouse Medical Center …

By adminApril 25, 2019Stem Cell Medical Center

Therapeutic STEM CELL THERAPY What is Regenerative Medicine & Therapeutic stem cell Treatment?

Wharton's Jelly or umbilical cord tissue contain many Regenerative factors like anti inflammatory cytokines, rowth factors, hyaluronic acid & Mesenchymal Stem Cells.

Lighthouse Medical Center offers treatments that are designed to kick start your own body's healing. Not a temporary fix or to act as a mask for pain. By building on what your body can innately do, and stimulating it in a very powerful way through a protocol of injections and therapies, stem cell and regenerative medicine can provide complete and total healing without the stress, cost, and downtime of surgery.

Featuring premium regenerative therapies including:CoreCyte, AmnioCyte Plus, PolyCyte and PRP therapeuticstem cell therapies, our treatments provide real healing for our patients!We use Cell products that contain Mesenchymal Stem Cells.

Join us for aFREE SEMINAR on stem cell therapy! Fill out the contact information below and we will reach out to you ! Lighthouse Medical Center has 1-2 seminars monthly.

Therapeutic stem cells are the body's raw materials cells from which all other cells with specialized functions are generated(Mayoclinic.org).

Over time our tissue can lose functionality due to age, injury, and disease. That can mean longer healing time, cellular aging and changing chemical environments. Fortunately, each person is born with building blocks capable of repairing and replenishing tissue.

We here at Lighthouse Medical Center use therapeutic stem cells and tissue products that are processed in an FDAregistered lab. The minimally manipulated tissue products are prepared to utilize proprietary extraction methods that reduce the loss of important cytokines, growth factors, proteins, and biomolecules.

Lighthouse Medical Center offers the mostinnovative techniques in Therapeutic stem cell and regenerative medicine therapies. We offer a plethora of therapies for various orthopedic conditions and injuries.

Therapeutic Stem cell and regenerative medicine at Lighthouse Medical Center includes the collection and use of therapeutic stem cells toincrease function, reduce the rate of degeneration, reduce inflammation, reduce scar tissue and promote healing in themusculoskeletal system, including: shoulders, elbows, wrists, hips, knees, ankles, neck and the back.

Just to name a few;

Mesenchymal stem cell

therapy also helps with :

Shoulder pain

Knee pain

Joint back

Back pain

Hip pain

osteoarthritis

If you have tennis elbow,

golfers elbow, plantar fasciitis

and rotator cuff injuriesand

are lookingfor a solution to

the challenges you face,

regenerative and Therapeutic

stem cell medicine therapies

might be exactly whats right

for you.

Dr. Beylers 3 Month Therapeutic Stem Cell Therapy Testimony

Knee And Hip One MonthTherapeutic Stem Cell Testimony

More:
Stem Cell Therapy | Lighthouse Medical Center ...

Braselton Georgia Stem Cell Therapy – Revive Medical Center

By adminApril 25, 2019Stem Cell Medical Center

Stem cells have been in the news a lot lately, and they have already proven their value in clinical trials and cutting edge medical treatments. Unlike other kinds of cells, stem cells have the ability to transform themselves. These unique cells can become any other type of cell, and that ability is what gives them their power.

Stem cells have been called many things, from the master cell of the human body to the building block of life. In the end, however, it does not matter what they are called what really matters is how they work.

There is a detailed scientific explanation of the stem cell, but what you really need to know is that these cells are undifferentiated. That undifferentiated status means that stem cells can transform themselves into virtually any type of cell in the body. Scientific studies and clinical trials have already shown that stem cells injected into heart muscle can become heart cells, and that adding stem cells to the brain can stimulate the growth of brain tissue.

In addition to their other abilities, stem cells may be a real alternative to invasive surgeries. If your doctor has suggested surgery to treat an exercise injury or other ailment, you owe it to yourself to check out stem cell therapy as an alternative.

Surgery can be effective, but there are significant downsides, including long recovery times and possible complications. Stem cells, on the other hand, can provide the effectiveness of surgery with none of the downside risk. If you think stem cells could be the answer, just give Revive Medical Center a call. Our stem cell therapy experts can assess the situation and provide a custom recommendation to treat your injury.

At Revive Medical Center, most of our Braselton, Georgia area residents are able to return to work the very same day. Instead of spending days in the hospital and weeks recuperating at home, our stem cell therapy patients can enjoy their lives and get back to work fast, with minimal downtime and no pain.

Professional athletes are already using stem cells to improve their game and get a new lease on life, and now Braselton area residents can do the same. Not all stem treatments are the same, and Revive Medical Center strives to be the best. Whether you have suffered an injury or just want to avoid surgery, you owe it to yourself to check out the power of stem cells.

More here:
Braselton Georgia Stem Cell Therapy - Revive Medical Center

Induced Pluripotent Stem Cells – Embryo Project

By adminApril 25, 2019Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells (iPSCs) are cells derived from non-pluripotent cells, such as adult somatic cells, that have been genetically manipulated so as to return to an undifferentiated, pluripotent state. Research on iPSCs, initiated by Shinya Yamanaka in 2006 and extended by James Thompson in 2007, has so far revealed the same properties as embryonic stem cells (ESCs), making their discovery potentially very beneficial for scientists and ethicists alike. By avoiding the destruction of embryos and the complicated technique and resource requirements of ESCs, iPSCs may prove more practical and attractive than ESC research in the study of pluripotent stem cells.

Yamanaka and his team were able to revert the differentiated cells to a pluripotent stage by using a retrovirus to insert specific genes known to be active in ESCs into the cells genome. Originally performed with mouse cells by Yamanaka and his team at Japans Kyoto University, both Yamanakas group and James Thompsons research team at University of Wisconsin, Madison, extended the technique to human somatic cells in November of 2007. A variety of genes and gene families have been identified as key components of a successful induction to the pluripotent state: Oct-3/4, the Sox family, the Klf family, the Myc family, Nanog, and LIN28. Additional genes that are expressed in ESCs include GDF3, REX1, FGF4, ESG1, DPPA2, DPPA4, and hTERT.

Unlike ESCs, iPSCs do not require embryos or even eggs from female donors a feature that has made them very appealing to scientists wishing to do work on pluripotent stem cells, which has heretofore been restricted in the United States and elsewhere due to ethical concerns and legal limitations. Though early work with iPSCs failed to produce living mice from embryos containing iPSCs, several research teams in the US and Japan achieved success after injecting iPSCs into developing embryos. The insertion of iPSCs into mice also originally caused high rates of cancerous tumors, but removal of the c-Myc genes from the retrovirus apparently eliminates the unusually high risk of cancer, according to further 2008 research by Yamanaka and his team.

Despite the genetic alteration involved in producing iPSCs, in most other aspects they are as yet indistinguishable from ESCs. In fact, the skills and resources required to produce iPSCs are significantly less labor-intensive and costly than those required for ESCs, in that most scientists with experience in genetic reprogramming can produce iPSCs. Neither iPSCs nor ESCs have yet been used in clinical treatments, though many researchers believe that undifferentiated cells hold even more potential for therapeutic applications than do adult stem cells, which are already used in a variety of therapies.

Immediately hailed by the media as the next step toward personalized medicine and the answer to the ESC research controversy, many researchers, ethicists, writers, and anti-ESC research groups have called for an end to or reduction in ESC research and funding. Scientists in the field, including some of the teams working with iPSCs, caution that it is still too soon to assume that iPSCs can replace ESCs in clinical potential and that ESC research will continue to be important in increasing sciences understanding of developmental biology. In addition, some scholars caution that iPSCs may eventually be altered to reach the totipotent state, which could nullify their ethical simplicity and place them on equal footing with embryos.

Though iPSCs show a great deal of potential for stem cell therapies and clinical applications, scientists are still in the fledgling research stages for this technology. If they surpass ESCs in practicality and success rates without totipotent capabilities, however, iPSCs may lay much of the ethical controversy surrounding ESC research to rest.

Brind'Amour, Katherine, "Induced Pluripotent Stem Cells".

(2010-05-06). ISSN: 1940-5030 http://embryo.asu.edu/handle/10776/1974.

Arizona State University. School of Life Sciences. Center for Biology and Society. Embryo Project Encyclopedia.

Arizona Board of Regents Licensed as Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported (CC BY-NC-SA 3.0) http://creativecommons.org/licenses/by-nc-sa/3.0/

Read the original post:
Induced Pluripotent Stem Cells - Embryo Project

A safe and potent anti-CD19 CAR T cell therapy | Nature …

By adminApril 25, 2019Uncategorized

Imai, C. et al. Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia. Leukemia 18, 676684 (2004).

Campana, D., Schwarz, H. & Imai, C. 4-1BB chimeric antigen receptors. Cancer J. 20, 134140 (2014).

Milone, M. C. et al. Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo. Mol. Ther. 17, 14531464 (2009).

Porter, D. L., Levine, B. L., Kalos, M., Bagg, A. & June, C. H. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N. Engl. J. Med. 365, 725733 (2011).

Maude, S. L. et al. Chimeric antigen receptor T cells for sustained remissions in leukemia. N. Engl. J. Med. 371, 15071517 (2014).

Maude, S. L. P. et al. Efficacy and safety of CTL019 in the first US phase II multicenter trial in pediatric relapsed/refractory acute lymphoblastic leukemia: results of an interim analysis. Blood 128, 2801 (2016).

Schuster, S. J. et al. Chimeric antigen receptor T cells in refractory B-cell lymphomas. N. Engl. J. Med. 377, 25452554 (2017).

Schuster, S. J. et al. Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma. N. Engl. J. Med. 380, 4556 (2019).

Eshhar, Z., Waks, T., Gross, G. & Schindler, D. G. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors. Proc. Natl Acad. Sci. USA 90, 720724 (1993).

Brentjens, R. J. et al. Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts. Clin. Cancer Res. 13, 54265435 (2007).

Kochenderfer, J. N. et al. Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19. Blood 116, 40994102 (2010).

Kalos, M. et al. T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Sci. Transl. Med. 3, 95ra73 (2011).

Kochenderfer, J. N. et al. B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells. Blood 119, 27092720 (2012).

Brentjens, R. J. et al. CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia. Sci. Transl. Med. 5, 177ra138 (2013).

Lee, D. W. et al. Current concepts in the diagnosis and management of cytokine release syndrome. Blood 124, 188195 (2014).

Turtle, C. J. et al. Immunotherapy of non-Hodgkins lymphoma with a defined ratio of CD8+ and CD4+CD19-specific chimeric antigen receptor-modified T cells. Sci. Transl. Med. 8, 355ra116 (2016).

Turtle, C. J. et al. CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients. J. Clin. Invest. 126, 21232138 (2016).

Neelapu, S. S. et al. Chimeric antigen receptor T-cell therapyassessment and management of toxicities. Nat. Rev. Clin. Oncol. 15, 4762 (2018).

Brudno, J. N. & Kochenderfer, J. N. Chimeric antigen receptor T-cell therapies for lymphoma. Nat. Rev. Clin. Oncol. 15, 3146 (2018).

Kelley, L. A. & Sternberg, M. J. Protein structure prediction on the Web: a case study using the Phyre server. Nat. Protoc. 4, 363371 (2009).

Wang, X. et al. A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells. Blood 118, 12551263 (2011).

Giavridis, T. et al. CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade. Nat. Med. 24, 731738 (2018).

Norelli, M. et al. Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells. Nat. Med. 24, 739748 (2018).

Kochenderfer, J. N. et al. Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor. J. Clin. Oncol. 33, 540549 (2015).

Porter, D. L. et al. Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia. Sci. Transl. Med. 7, 303ra139 (2015).

Teachey, D. T. et al. Identification of predictive biomarkers for cytokine release syndrome after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia. Cancer Discov. 6, 664679 (2016).

Brudno, J. N. & Kochenderfer, J. N. Toxicities of chimeric antigen receptor T cells: recognition and management. Blood 127, 33213330 (2016).

Gattinoni, L. et al. A human memory T cell subset with stem cell-like properties. Nat. Med. 17, 12901297 (2011).

Farber, D. L., Yudanin, N. A. & Restifo, N. P. Human memory T cells: generation, compartmentalization and homeostasis. Nat. Rev. Immunol. 14, 2435 (2014).

Wang, A. et al. The stoichiometric production of IL-2 and IFN- mRNA defines memory T cells that can self-renew after adoptive transfer in humans. Sci. Transl. Med. 4, 149ra120 (2012).

Hudecek, M. et al. The nonsignaling extracellular spacer domain of chimeric antigen receptors is decisive for in vivo antitumor activity. Cancer Immunol. Res. 3, 125135 (2015).

Alabanza, L. et al. Function of novel anti-CD19 chimeric antigen receptors with human variable regions is affected by hinge and transmembrane domains. Mol. Ther. 25, 24522465 (2017).

Waage, A., Brandtzaeg, P., Halstensen, A., Kierulf, P. & Espevik, T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J. Exp. Med. 169, 333338 (1989).

Oliver, J. C. et al. Cytokine kinetics in an in vitro whole blood model following an endotoxin challenge. Lymphokine Cytokine Res. 12, 115120 (1993).

Salter, A. I. et al. Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function. Sci. Signal. 11, eaat6753 (2018).

Marasco, W. A., Haseltine, W. A. & Chen, S. Y. Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody. Proc. Natl Acad. Sci. USA 90, 78897893 (1993).

Shen, L., Evel-Kabler, K., Strube, R. & Chen, S. Y. Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumor immunity. Nat. Biotechnol. 22, 15461553 (2004).

Song, X. T. et al. A20 is an antigen presentation attenuator, and its inhibition overcomes regulatory T cell-mediated suppression. Nat. Med. 14, 258265 (2008).

Wang, D. et al. Efficacy of intracellular immune checkpoint-silenced DC vaccine. JCI Insight 3, e98368 (2018).

Jiang, X. X. et al. Control of B cell development by the histone H2A deubiquitinase MYSM1. Immunity 35, 883896 (2011).

Read the original:
A safe and potent anti-CD19 CAR T cell therapy | Nature ...

Creating Embryonic Stem Cells Without Embryo Destruction

By adminApril 23, 2019Embryonic Stem Cells

By: Ian Murnaghan BSc (hons), MSc - Updated: 12 Sep 2015 | *Discuss

One of the biggest hurdles in stem cell research involves the use of embryonic stem cells. While these stem cells have the greatest potential in terms of their ability to differentiate into many different kinds of cells in the human body, they also bring with them enormous ethical controversies. The extraction of embryonic stem cells involves the destruction of an embryo, which upsets and outrages some policy makers and researchers as well as a number of public members. Not only that, but actually obtaining them is a challenge in itself and one that has become more difficult in places such as the United States, where policies have limited the availability of embryonic stem cells for use.

Although researchers have focused on harnessing the power of adult stem cells, there have still been many difficulties in the practical aspects of these potential therapies. In an ideal world, we would be able to use embryonic stem cells without destroying an embyro. Now, however, this ideal hope may actually have some realistic basis. In recent medical news, there has been important progress in the use of embryonic stem cells.

There are still many more tests and research that must be conducted to verify the safety and reliability of the procedure but it is indeed hopeful that funding can now increase for stem cell research. If you are an avid reader of health articles, you will probably be able to stay up-to-date on the latest developments related to this medical news. This newest research into embryonic stem cells holds promise and hope for appeasing the controversy around embryonic stem cell use and allowing for research to finally move forward with fewer challenges and controversies. For those who suffer from one of the many debilitating diseases and conditions that stem cell treatments may help or perhaps cure one day, this is welcome news.

Knees – Stem Cell Therapy For Pain | Stem Cell Seminars …

By adminApril 22, 2019Stem Cell Treatment

Surgical options for those suffering from painful knee injuries can range from knee surgery to complete knee replacement. Recent studies have shown that most surgeries dont have a 100% success rate and there is chance of the pain and discomfort resurfacing. Knee replacement surgery can be extremely traumatic and it has the risk of toxic artificial particles entering the bloodstream. Apart from this, months of a painful recovery phase is required to regain the strength and mobility following the surgeries. Most surgeries also boost the degeneration process, which can lead to osteoarthritis.

Knee replacement surgery carries many serious risks and complications, but is often considered as the most-accepted treatment method for those dealing with significant arthritis or injury in knee joints.

Surgery should always be the last option, however, it is often perceived to be the only treatment alternative by most patients. At Stem Cell Therapy for Pain, we have assisted several patients with severe arthritis problems in avoiding knee replacement surgery through stem cell treatment for knees, which enabled them to carry out the things they love without being burdened by pain. We have seen exciting results on tricky knee injury cases, including complete ligament and muscle tears. Our expert physicians ensure that patients experience little to no downtime after the treatment, and can bounce back to their daily routine immediately.

The most common form of arthritis is Osteoarthritis. It is also known as wear-and-tear arthritis, since the cartilage thins and eventually breaks down. The cartilage cushions the joints where two bones meet, so any degeneration can seriously impact our body.

Stem cell treatments for knees offered by Stem Cell Therapy for Pain are designed to target the knee joints to assist with the formation of new cartilage cells. The aim of each stem cell injection for knee pain is to re-inject the amniotic or adult stem cells into the knee joint to boost cartilage or chondrocytes cell creation. Stem cells have a natural anti-inflammatory chemical that helps to alleviate osteoarthritis pain and inflammation in the knee joint.

If you have chronic knee pain due to a past injury or arthritis, an injury to the knee cartilage, meniscus, ligaments, you might be an ideal candidate for stem cell therapy for knees.

To learn more about services like stem cell therapy for osteoarthritis, get in touch with us today. Lets work on restoring your life, one treatment at a time!

View original post here:
Knees - Stem Cell Therapy For Pain | Stem Cell Seminars ...

What Are Stem Cells? – livescience.com

By adminApril 19, 2019Embryonic Stem Cells

The term "stem cells" has become part of the mainstream lexicon, likely to be overheard in conversations anywhere from a baseball game to cocktail get-togethers. But what exactly are these cells?

Along with phrases such as "that's just immoral" or "stem cells could be the end-all cure," one could easily weave in some technical tidbits about these microscopic, yet significant, cells.

Stem cellsare considered the "engine" cells of regeneration in that they are self-renewing and able to duplicate, or clone, themselves. These special cells are used in the rapidly growing field of regenerative medicine to halt or even reverse chronic diseases. Regenerative medicine seeks torepair or replace tissues or organsthat have been damaged by trauma, disease or congenital defects, according to theMcGowan Institute for Regenerative Medicineat the University of Pittsburgh.

There are three types of stem cells: embryonic, umbilical cord (also known as mesenchymal, or MSC), and adult stem cells. Embryonic stem cells are considered pluripotent, meaning they can give rise to all of the cell types that make up the human body. Cord and adult stem cells are multipotent, which means that they are able to develop into more than one cell type, but they are more limited than pluripotent cells, according toNYSTEM (New York Stem Cell Science).

In the United States, cord and adult stem cells are the only ones used in regenerative medical procedures. Due to ethical controversy, embryonic stem cells are not used in clinical practice but can be used for research purposes. [How Stem Cell Cloning Works (Infographic)]

Adult stem cells which can be taken from bone marrow, blood or fat are mostly free of ethical controversy, but they have limited potential. As we get older, not only do our stem cells lose functionality, but we have far fewer of them. Researchers estimate that newborns have 40 times more stem cells in their bone marrow compared to a 50 year old, according to a 2009 study in theJournal of Pathology. In addition, adult stem cells may be subject to DNA abnormalities caused by sunlight, toxins and errors associated with making more DNA copies over the course of a lifetime, according to theNational Institutes of Health (NIH).

Cord stem cells can be harvested from the umbilical cord after birth with the mother's permission. This tissue, which is typically discarded, can be donated to science for use in research or medicine, or placed in a cord bank in case the mother or child may need it one day.

Cord stem cellsare much more efficient at replicatingonce removed from the body compared to adult stem cells. For example, when placed in a petri dish with the proper nutrients, one cord stem cell will multiply into 1 billion cells in 30 days, whereas one adult stem cell will multiply into only around 200 cells in 30 days, according to a 2011 study published in the journalOrthopedics.

Doctors use cord stem cells to treat autoimmune conditions, such aslupus,rheumatoid arthritisandmultiple sclerosis, as well as chronic infections such asHIV, herpes and Lyme disease, according toAMA.

Embryonic stem cells hold the most promise for treating diseases, but heated debate abounds over the ethics of using them.Human embryonic stem cellsare derived from eggs fertilized in vitro (outside of the body) and are somewhat pristine. These pluripotent stem cells are prized for their flexibility in being able to morph into any human cell.

When embryonic stem cells are grown in a laboratory under certain conditions for several months, they can remain unspecialized and produce millions of stem cells indefinitely. The resulting batch of cells is referred to as a stem-cell line.

The NIH said 64 embryonic stem-cell lines existed as of August 2001 when President Bush announced the federal policy describing the constraints on funds for stem-cell research. In March 2009, however, President Obama officially removed the restrictions placed by President Bush on federal funding for research on embryos. Although it's been contested, the policy remains in effect withstrict guidelines in place by the NIH.

Scientists can now reprogram adult stem cells to become more like embryonic stem cells. These are known as induced pluripotent stem cells (iPSCs). But since iPSCs are still adult stem cells, they carry the risk of having abnormalities. Much more research is needed on iPSCs, but scientists hope to use them in transplantation medicine, according to theNIH.

Additional resources:

This article was updated on April 15, 2019 by Live Science Contributor Traci Pedersen.

See the article here:
What Are Stem Cells? - livescience.com